Search Within

Michael Andrew Postow

Formats
  1. Journal Article (196)
  2. Meeting Abstract (138)
  3. Review (10)
  4. Editorial (9)
  5. Book Section (4)
  6. Guidelines (4)
  7. Research Letter (4)
  8. Miscellaneous (2)
  9. Book Whole (1)
  10. Correspondence (1)
Groups
  1. Department of Medicine (369)
  2. Melanoma Disease Management Team (369)
  3. Melanoma and Immunotherapeutics Service (369)
  4. Solid Tumor Oncology Division (369)
  5. GSK Faculty (178)
  6. Hematologic Malignancies, Division of (105)

More Groups

People
  1. Jedd Wolchok (158)
  2. Margaret Callahan (96)
  3. Katherine Panageas (66)
  4. Alexander Shoushtari (64)
  5. Paul Chapman (55)
  6. Parisa Momtaz (37)

More People

Years
  1. 2025 (23)
  2. 2024 (19)
  3. 2023 (23)
  4. 2022 (23)
  5. 2021 (27)
  6. 2020 (30)

More Years

Publications
  1. Journal of Clinical Oncology (92)
  2. Journal for ImmunoTherapy of Cancer (34)
  3. Clinical Cancer Research (16)
  4. Annals of Oncology (13)
  5. International Journal of Radiation Oncology, Biology, Physics (12)
  6. The Oncologist (12)

More Publications

Publishers
  1. American Society of Clinical Oncology (94)
  2. Biomed Central Ltd (43)
  3. Elsevier Inc. (32)
  4. Oxford University Press (32)
  5. American Association for Cancer Research (24)
  6. Wiley Blackwell (21)

More Publishers

Results (369)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of infliximab dose escalation in patients with refractory immunotherapy-related colitis: A case series
    Review

    Harris, J. P.; Postow, M. A.; Faleck, D. M.
    The Oncologist (2022)

    Fulltext@MSK | Save
  • Facts and hopes in prediction, diagnosis, and treatment of immune-related adverse events
    Review

    Smithy, J. W.; Faleck, D. M.; Postow, M. A.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
    Journal Article

    Chowell, D.; Yoo, S. K.; Valero, C.; Pastore, A.; Krishna, C.; Lee, M.; Hoen, D.; Shi, H.; Kelly, D. W.; Patel, N.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Early readout on overall survival of patients with melanoma treated with immunotherapy using a novel imaging analysis
    Journal Article

    Dercle, L.; Zhao, B.; Gönen, M.; Moskowitz, C. S.; Firas, A.; Beylergil, V.; Connors, D. E.; Yang, H; Lu, L.; Fojo, T.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition
    Journal Article

    Ghosh, N.; Postow, M.; Zhu, C.; Jannat-Khah, D.; Li, Q. Z.; Vitone, G.; Chan, K. K.; Bass, A. R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Ipilimumab alone or in combination with nivolumab in patients with advanced melanoma who have progressed or relapsed on PD-1 blockade: Clinical outcomes and translational biomarker analyses
    Journal Article

    Friedman, C. F.; Spencer, C.; Cabanski, C. R.; Panageas, K. S.; Wells, D. K.; Ribas, A.; Tawbi, H.; Tsai, K.; Postow, M.; Shoushtari, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Factors determining long-term antitumor responses to immune checkpoint blockade therapy in melanoma
    Journal Article

    Loo, K.; Smithy, J. W.; Postow, M. A.; Betof Warner, A.
    Frontiers in Immunology (2022)

    Fulltext@MSK | Save
  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients
    Journal Article

    Nguyen, B.; Fong, C.; Luthra, A.; Smith, S. A.; DiNatale, R. G.; Nandakumar, S.; Walch, H.; Chatila, W. K.; Madupuri, R.; Kundra, R.; more...
    Cell (2022)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): Final results of an open-label, multicentre, phase 2 study
    Journal Article

    Tawbi, H. A.; Forsyth, P. A.; Hodi, F. S.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Moschos, S. J.; Atkins, M. B.; Lewis, K.; Postow, M. A.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067
    Journal Article

    Regan, M. M.; Mantia, C. M.; Werner, L.; Tarhini, A. A.; Larkin, J.; Hodi, F. S.; Wolchok, J.; Postow, M. A.; Stwalley, B.; Moshyk, A.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save